Clinical Trials · NCT01825148
GLP-1 Receptor Targeting in Diabetic and Healthy Individuals
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Radboud University Medical Center
- Enrollment
- 20
- Start date
- Dec 2012
- Locations
- 1 site, Netherlands
- Primary endpoint
- pancreatic uptake of radiolabeled Exendin